Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling

Identifying molecular residual disease (MRD) after treatment of localized lung cancer could facilitate early intervention and personalization of adjuvant therapies. Here, we apply cancer personalized profi ling by deep sequencing (CAPP-seq) circulating tumor DNA (ctDNA) analysis to 255 samples from...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Discov
Main Authors: Chaudhuri, Aadel A., Chabon, Jacob J., Lovejoy, Alexander F., Newman, Aaron M., Stehr, Henning, Azad, Tej D., Khodadoust, Michael S., Esfahani, Mohammad Shahrokh, Liu, Chih Long, Zhou, Li, Scherer, Florian, Kurtz, David M., Say, Carmen, Carter, Justin N., Merriott, David J., Dudley, Jonathan C., Binkley, Michael S., Modlin, Leslie, Padda, Sukhmani K., Gensheimer, Michael F., West, Robert B., Shrager, Joseph B., Neal, Joel W., Wakelee, Heather A., Loo, Billy W., Alizadeh, Ash A., Diehn, Maximilian
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5895851/
https://ncbi.nlm.nih.gov/pubmed/28899864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-17-0716
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados